Skip to content
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Neurology · Developmental and Epileptic Encephalopathy 85

Diagnostic Tests and Imaging

At a Glance

DEE85 is diagnosed primarily through genetic testing that identifies an SMC1A variant and confirms the clinical picture of seizures. Brain MRI may be normal or show midline changes, but imaging findings are not required to establish the diagnosis or automatically require repeat scans.

Confirming a diagnosis of Developmental and Epileptic Encephalopathy 85 (DEE85) is a process of looking both at the “software” of the brain (the genetic code) and its “hardware” (the physical structure). Because this condition is so rare and its physical features can be subtle, specialized tools are required to provide a clear answer.

Genetic Testing: Whole Exome Sequencing (WES) and Panels

While some genetic conditions can be identified by looking at a child’s facial features or growth patterns, DEE85 does not have a single, recognizable “look” (phenotype) that applies to every child [1][2]. For this reason, Whole Exome Sequencing (WES) or a targeted epilepsy panel is often required for diagnosis [1].

  • How it Works: WES does not just look at one gene; it scans all the “exons”—the parts of the DNA that provide instructions for making proteins [3].
  • Why it’s Preferred: In many cases of epilepsy and developmental delay, WES has a higher “diagnostic yield” (success rate in finding the cause) than smaller, targeted gene panels [3][4]. It is particularly effective at finding the various types of SMC1A variants—such as frameshift or nonsense mutations—that cause DEE85 [1][5]. Exome testing can sometimes miss copy-number or mosaic variants; if testing is negative or results in a “Variant of Uncertain Significance” (VUS), ask your geneticist about re-testing or periodic data reanalysis.

Brain Imaging: What the MRI Reveals

Once a genetic diagnosis is confirmed, doctors use Magnetic Resonance Imaging (MRI) to look at the physical layout of the brain. While the genetic change is present in every cell, it does not always cause a change you can see on a scan. In fact, in a small study of females with DEE85-causing variants, 62% had a completely normal brain MRI [6].

However, approximately 20% of children with DEE85 are found to have Central Nervous System (CNS) malformations [1].

Understanding Structural Brain Findings

The “midline” refers to the structures that sit directly in the center of the brain, acting as bridges or anchors between the left and right sides. In DEE85, several specific areas are carefully evaluated by neuroradiologists:

  • Corpus Callosum: This is the main “bridge” of nerve fibers connecting the two halves of the brain. Some children with DEE85 have a thin corpus callosum, which can affect how the two sides of the brain communicate [6].
  • Cerebellum: Located at the back of the brain (posterior fossa), this area controls balance and motor coordination. Reports have noted cerebellar atrophy (thinning or shrinking of this tissue) in some patients [6][7].
  • Ventricles: These are the paired fluid-filled spaces inside the brain. An MRI may show ventricular enlargement, which has many possible causes and does not automatically mean surrounding brain tissue is damaged [6].

Why Imaging Matters

It is important to remember that having a structural brain defect does not change the diagnosis—the diagnosis is defined by the SMC1A variant and the presence of seizures [1]. However, knowing if a defect is present helps your care team:

  1. Refine the Clinical Picture: It helps explain specific physical challenges, such as difficulties with balance if the cerebellum is involved [7].
  2. Monitor Progress: A structural finding does not automatically require serial MRIs; follow-up scans should only be performed when your neurologist identifies a specific clinical indication [7].
  3. Differentiate from Other Conditions: While DEE85 shares a gene with Cornelia de Lange Syndrome (CdLS), the structural brain findings in DEE85 are often more central to the child’s neurological challenges [1].

Your child’s MRI report may contain complex terms, but its primary purpose is to help your neurologist see the “map” of your child’s brain as they navigate the path of treatment.

Common questions in this guide

How is DEE85 diagnosed?
DEE85 is diagnosed by identifying a disease-causing SMC1A variant and confirming the child’s seizure history and clinical findings. Whole exome sequencing or a targeted epilepsy panel may be used, while brain MRI can show structural differences but is not required to establish the diagnosis.
Which genetic test is usually used for DEE85?
Doctors may use whole exome sequencing, which examines the protein-coding parts of many genes, or a targeted epilepsy panel. These tests can identify SMC1A variants linked to DEE85. If testing is negative or reports a variant of uncertain significance, the genetics team may discuss reanalysis, repeat testing, or additional testing.
Can a child with DEE85 have a normal brain MRI?
Yes. Many children with DEE85 have no visible structural abnormality on MRI, so a normal scan does not rule out the condition. Diagnosis is based mainly on the SMC1A genetic result and seizure history, not on whether the MRI shows a brain defect.
What brain changes can appear on an MRI with DEE85?
An MRI may show a thin corpus callosum, changes in the cerebellum such as atrophy, or enlarged ventricles. These findings vary from child to child, and enlarged ventricles do not automatically mean surrounding brain tissue is damaged. A neuroradiologist and neurologist interpret the findings in context.
Does my child need repeat MRI scans after a DEE85 diagnosis?
Not automatically. Follow-up imaging is generally considered when the neurologist identifies a specific clinical reason, rather than simply because DEE85 was diagnosed. Ask what change in symptoms or examination would make another MRI useful.
What does a variant of uncertain significance mean in DEE85 testing?
A variant of uncertain significance is a genetic change whose meaning is not yet clear. It should not be treated as a confirmed cause of DEE85 without additional evidence. Your genetics team can review new information and may recommend reanalysis or another test over time.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on developmental and epileptic encephalopathy, 85, with or without midline brain defects.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my child's genetic diagnosis confirmed via a targeted epilepsy panel or Whole Exome Sequencing, and is there any need for re-testing?
  2. 2.If our genetic result is listed as a 'Variant of Uncertain Significance' (VUS), what is the plan and timeline for re-evaluating that result?
  3. 3.Did the MRI reveal any structural changes in my child's brain, and how do those specific findings influence their daily care or therapies?
  4. 4.Does my child's current clinical picture warrant a follow-up MRI, or is their current imaging sufficient for our ongoing management plan?

References

References (7)
  1. 1

    SMC1A epilepsy syndrome: clinical data from a large international cohort.

    Gibellato E, Cianci P, Mariani M, et al.

    American journal of medical genetics. Part A 2024; (194(7)):e63577 doi:10.1002/ajmg.a.63577.

    PMID: 38421079
  2. 2

    Phenotypes and genotypes in individuals with SMC1A variants.

    Huisman S, Mulder PA, Redeker E, et al.

    American journal of medical genetics. Part A 2017; (173(8)):2108-2125 doi:10.1002/ajmg.a.38279.

    PMID: 28548707
  3. 3

    Genetic testing for diagnosing neurodevelopmental disorders and epilepsy: a systematic review and meta-analysis.

    Chang YM, Huang YT, Lai PC

    Systematic reviews 2025; (14(1)):155 doi:10.1186/s13643-025-02896-y.

    PMID: 40722196
  4. 4

    Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort.

    Rochtus A, Olson HE, Smith L, et al.

    Epilepsia 2020; (61(2)):249-258 doi:10.1111/epi.16427.

    PMID: 31957018
  5. 5

    Novel SMC1A frameshift mutations in children with developmental delay and epilepsy.

    Goldstein JH, Tim-Aroon T, Shieh J, et al.

    European journal of medical genetics 2015; (58(10)):562-8.

    PMID: 26386245
  6. 6

    [Developmental and epileptic encephalopathy 85 caused by SMC1A gene truncating variation: 4 cases report and literature review].

    Ye YZ, Duan J, Hu ZQ, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2022; (60(6)):583-587 doi:10.3760/cma.j.cn112140-20211126-00994.

    PMID: 35658367
  7. 7

    Early onset developmental and epileptic encephalopathy and Rett-like phenotype in a 15-year-old girl affected by Cornelia de Lange syndrome type 2 due to a SMC1A gene mutation.

    Parmeggiani L, Stanzial F, Menna E, et al.

    Epilepsy & behavior reports 2023; (24()):100634 doi:10.1016/j.ebr.2023.100634.

    PMID: 38076278

This page explains DEE85 genetic testing and brain MRI findings for informational purposes only and does not constitute medical advice. Your child's neurologist and genetics team should interpret the results and recommend follow-up.